{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:03:42Z","timestamp":1781978622905,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.rdc.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T23:37:20Z","timestamp":1362785840000},"page":"365-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Retroperitoneal Fibrosis"],"prefix":"10.1016","volume":"39","author":[{"suffix":"Jr.","given":"Paul J.","family":"Scheel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Feeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib1","first-page":"231","article-title":"Retroperitoneal fibrosis","volume":"60","author":"van Bommel","year":"2002","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.60.4.427","article-title":"Treatment of idiopathic retroperitoneal fibrosis using cyclosporin","volume":"60","author":"Marzano","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02207688","article-title":"Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis","volume":"14","author":"Scavalli","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib4","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"9135","key":"10.1016\/j.rdc.2013.02.004_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(05)60533-8","article-title":"Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids","volume":"352","author":"Grotz","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.004_bib7","first-page":"776","article-title":"Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis","volume":"30","author":"Catanoso","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2013.02.004_bib8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/MEG.0b013e3283297417","article-title":"Allergic manifestations in autoimmune pancreatitis","volume":"21","author":"Kamisawa","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.ajkd.2008.09.025","article-title":"Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series","volume":"53","author":"Vega","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2214\/ajr.164.2.7840016","article-title":"Treatment of retroperitoneal fibrosis with tamoxifen","volume":"164","author":"Spillane","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","article-title":"Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation","volume":"88","author":"Scheel","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.004_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-010-1580-6","article-title":"Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review","volume":"30","author":"Li","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.02.004_bib13","article-title":"Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature","author":"Gomez Garcia","year":"2012","journal-title":"Scand J Urol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-154-1-201101040-00005","article-title":"Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series","volume":"154","author":"Scheel","year":"2011","journal-title":"Ann Intern Med"},{"issue":"9419","key":"10.1016\/j.rdc.2013.02.004_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(04)16100-X","article-title":"Asbestos exposure as a risk factor for retroperitoneal fibrosis","volume":"363","author":"Uibu","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.004_bib16","first-page":"250","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"81","author":"Koep","year":"1977","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib17","first-page":"179","article-title":"Ergotamine as a possible cause of retroperitoneal fibrosis","volume":"1","author":"Lepage-Savary","year":"1982","journal-title":"Clin Pharm"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0002-8703(96)90074-5","article-title":"Association of metoprolol and retroperitoneal fibrosis","volume":"131","author":"Ahmad","year":"1996","journal-title":"Am Heart J"},{"issue":"6154","key":"10.1016\/j.rdc.2013.02.004_bib19","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/bmj.2.6154.1786-b","article-title":"Retroperitoneal fibrosis after treatment with atenolol","volume":"2","author":"Doherty","year":"1978","journal-title":"Br Med J"},{"issue":"8319","key":"10.1016\/j.rdc.2013.02.004_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0140-6736(83)91715-4","article-title":"Retroperitoneal fibrosis associated with timolol","volume":"1","author":"Rimmer","year":"1983","journal-title":"Lancet"},{"issue":"5962","key":"10.1016\/j.rdc.2013.02.004_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bmj.2.5962.76","article-title":"Analgesic abuse, ureteric obstruction, and retroperitoneal fibrosis","volume":"2","author":"Lewis","year":"1975","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0002-8703(83)90412-X","article-title":"Methyldopa and retroperitoneal fibrosis","volume":"105","author":"Ahmad","year":"1983","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib23","first-page":"936","article-title":"Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report","volume":"141","author":"Waters","year":"1989","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/(SICI)1097-0274(199804)33:4<418::AID-AJIM13>3.0.CO;2-1","article-title":"Asbestos exposure: a potential cause of retroperitoneal fibrosis","volume":"33","author":"Sauni","year":"1998","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.rdc.2013.02.004_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-3-29","article-title":"Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis","volume":"3","author":"Uibu","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-8140(95)01540-W","article-title":"Cellular basis of radiation-induced fibrosis","volume":"35","author":"Rodemann","year":"1995","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib27","first-page":"526","article-title":"Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry","volume":"185","author":"Brandt","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"12","key":"10.1016\/j.rdc.2013.02.004_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0022-3468(87)80715-7","article-title":"Familial retroperitoneal fibrosis","volume":"22","author":"Doolin","year":"1987","journal-title":"J\u00a0Pediatr Surg"},{"issue":"8","key":"10.1016\/j.rdc.2013.02.004_bib29","first-page":"1025","article-title":"Retroperitoneal fibrosis in three siblings with the sickle cell trait","volume":"108","author":"Phills","year":"1973","journal-title":"Can Med Assoc J"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib30","first-page":"746","article-title":"Idiopathic retroperitoneal fibrosis in twins","volume":"131","author":"Duffy","year":"1984","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/art.21698","article-title":"Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin","volume":"55","author":"Martorana","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"866","key":"10.1016\/j.rdc.2013.02.004_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1259\/bjr.73.866.10884739","article-title":"Retroperitoneal fibrosis: typical and atypical manifestations","volume":"73","author":"Vivas","year":"2000","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.004_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/kem328","article-title":"Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature","volume":"47","author":"Vaglio","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(03)00056-1","article-title":"Evidence of autoimmunity in chronic periaortitis: a prospective study","volume":"114","author":"Vaglio","year":"2003","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.rdc.2013.02.004_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.autrev.2006.03.011","article-title":"Autoimmune aspects of chronic periaortitis","volume":"5","author":"Vaglio","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"9506","key":"10.1016\/j.rdc.2013.02.004_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.004_bib39","first-page":"784","article-title":"Retroperitoneal fibrosis revisited","volume":"110","author":"Mitchinson","year":"1986","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0021-9150(86)90070-5","article-title":"The localisation of immunoglobulin in chronic periaortitis","volume":"61","author":"Parums","year":"1986","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib41","first-page":"383","article-title":"Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis","volume":"114","author":"Parums","year":"1990","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib42","first-page":"385","article-title":"Idiopathic retroperitoneal fibrosis: a discussion of the etiology","volume":"94","author":"Ormond","year":"1965","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.rdc.2013.02.004_bib43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jcp.23.8.681","article-title":"The pathology of idiopathic retroperitoneal fibrosis","volume":"23","author":"Mitchinson","year":"1970","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1523-1755.2005.00434.x","article-title":"Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease","volume":"68","author":"Moroni","year":"2005","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.rdc.2013.02.004_bib45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM200009143431106","article-title":"The HLA System","volume":"343","author":"Klein","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.004_bib46","first-page":"373","article-title":"Retroperitoneal fibrosis associated with systemic lupus erythematosus: a case report and brief review","volume":"11","author":"Lichon","year":"1984","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.10267","article-title":"Retroperitoneal fibrosis: an extraarticular manifestation of ankylosing spondylitis","volume":"47","author":"LeBlanc","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2013.02.004_bib48","first-page":"1147","article-title":"The association of idiopathic retroperitoneal fibrosis and ankylosing spondylitis","volume":"19","author":"De la Iglesia Martinez","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archophthalmol.2011.16","article-title":"Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease","volume":"129","author":"Plaza","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PAS.0b013e3182027717","article-title":"Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance","volume":"35","author":"Deshpande","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/BOR.0b013e3283413011","article-title":"IgG4-associated sialadenitis","volume":"23","author":"Geyer","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-010-0746-2","article-title":"IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria","volume":"120","author":"Lindstrom","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.rdc.2013.02.004_bib53","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","volume":"96","author":"Leporati","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.rdc.2013.02.004_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","article-title":"IgG4-related disease: historical overview and pathology of hematological disorders","volume":"60","author":"Sato","year":"2010","journal-title":"Pathol Int"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.004_bib55","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/acr.20215","article-title":"Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum","volume":"62","author":"Dahlgren","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib56","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2511080965","article-title":"Immunoglobulin G4-related lung disease: CT findings with pathologic correlations","volume":"251","author":"Inoue","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/BOR.0b013e3283412f7c","article-title":"Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease","volume":"23","author":"Stone","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","article-title":"Differences in clinical profile and relapse rate of type 1 versus type\u00a02 autoimmune pancreatitis","volume":"139","author":"Sah","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.rdc.2013.02.004_bib59","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int"},{"issue":"25","key":"10.1016\/j.rdc.2013.02.004_bib60","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1056\/NEJMra061200","article-title":"Autoimmune pancreatitis","volume":"355","author":"Finkelberg","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.004_bib61","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.02.004_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","article-title":"Clinical significance of immunoglobulin G4-associated autoimmune hepatitis","volume":"46","author":"Umemura","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MPA.0b013e3181577553","article-title":"Circulating naive and CD4+ CD25 high regulatory T cells in patients with autoimmune pancreatitis","volume":"36","author":"Miyoshi","year":"2008","journal-title":"Pancreas"},{"issue":"12","key":"10.1016\/j.rdc.2013.02.004_bib64","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","article-title":"Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.ki.5002427","article-title":"Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis","volume":"72","author":"Corradi","year":"2007","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.rdc.2013.02.004_bib66","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e31826b1c1d","article-title":"Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients","volume":"91","author":"Mirault","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2007.01805.x","article-title":"Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study","volume":"262","author":"van Bommel","year":"2007","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.20914","article-title":"(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis","volume":"53","author":"Vaglio","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9788","key":"10.1016\/j.rdc.2013.02.004_bib69","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial","volume":"378","author":"Vaglio","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.02.004_bib70","article-title":"Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis","author":"van Bommel","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2013.02.004_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12016-009-8157-7","article-title":"Antifibrosis: to reverse the irreversible","volume":"38","author":"Paz","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-144-2-200601170-00007","article-title":"Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis","volume":"144","author":"van Bommel","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.rdc.2013.02.004_bib73","first-page":"842","article-title":"Retroperitoneal fibrosis treated with tamoxifen","volume":"61","author":"Owens","year":"1995","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.rdc.2013.02.004_bib74","first-page":"231","article-title":"Treatment of idiopathic retroperitoneal fibrosis by tamoxifen","volume":"163","author":"Tonietto","year":"1997","journal-title":"Eur J Surg"},{"issue":"2","key":"10.1016\/j.rdc.2013.02.004_bib75","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1152\/ajprenal.00442.2004","article-title":"Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril","volume":"289","author":"Kramer","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.rdc.2013.02.004_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1523-1755.2000.00140.x","article-title":"Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney","volume":"58","author":"Badid","year":"2000","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.rdc.2013.02.004_bib77","first-page":"1072","article-title":"Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process","volume":"59","author":"Ormond","year":"1948","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.rdc.2013.02.004_bib78","article-title":"Use of full-length metallic stents in malignant ureteral obstruction","author":"Abbasi","year":"2012","journal-title":"J\u00a0Endourol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:11:50Z","timestamp":1760181110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0889857X13000057"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.02.004","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retroperitoneal Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}